nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—AOX1—Mercaptopurine—Crohn's disease	0.504	0.894	CbGbCtD
Zonisamide—CYP2C19—Prednisone—Crohn's disease	0.0401	0.0711	CbGbCtD
Zonisamide—CYP3A4—Prednisone—Crohn's disease	0.0194	0.0344	CbGbCtD
Zonisamide—CA13—gall bladder—Crohn's disease	0.013	0.0931	CbGeAlD
Zonisamide—CA13—mouth—Crohn's disease	0.0116	0.0828	CbGeAlD
Zonisamide—CA9—gall bladder—Crohn's disease	0.00638	0.0456	CbGeAlD
Zonisamide—CA6—mouth—Crohn's disease	0.00626	0.0448	CbGeAlD
Zonisamide—CA3—mouth—Crohn's disease	0.00592	0.0424	CbGeAlD
Zonisamide—SCN4B—mammalian vulva—Crohn's disease	0.00569	0.0407	CbGeAlD
Zonisamide—CA13—digestive system—Crohn's disease	0.00512	0.0366	CbGeAlD
Zonisamide—CA11—mammalian vulva—Crohn's disease	0.0049	0.0351	CbGeAlD
Zonisamide—AOX1—gall bladder—Crohn's disease	0.00394	0.0282	CbGeAlD
Zonisamide—SCN1B—lymph node—Crohn's disease	0.00363	0.026	CbGeAlD
Zonisamide—SCN11A—digestive system—Crohn's disease	0.0035	0.0251	CbGeAlD
Zonisamide—CA8—lymph node—Crohn's disease	0.00342	0.0244	CbGeAlD
Zonisamide—SCN3B—lymph node—Crohn's disease	0.00335	0.024	CbGeAlD
Zonisamide—CACNA1G—digestive system—Crohn's disease	0.00334	0.0239	CbGeAlD
Zonisamide—CA13—lymph node—Crohn's disease	0.00292	0.0209	CbGeAlD
Zonisamide—CA7—digestive system—Crohn's disease	0.00286	0.0205	CbGeAlD
Zonisamide—SCN4B—lymph node—Crohn's disease	0.00285	0.0204	CbGeAlD
Zonisamide—CACNA1I—lymph node—Crohn's disease	0.00278	0.0199	CbGeAlD
Zonisamide—CACNA1H—smooth muscle tissue—Crohn's disease	0.00277	0.0198	CbGeAlD
Zonisamide—CA9—digestive system—Crohn's disease	0.00251	0.018	CbGeAlD
Zonisamide—CA11—lymph node—Crohn's disease	0.00245	0.0176	CbGeAlD
Zonisamide—CA2—gall bladder—Crohn's disease	0.00242	0.0173	CbGeAlD
Zonisamide—CA2—mouth—Crohn's disease	0.00215	0.0154	CbGeAlD
Zonisamide—CA5B—mammalian vulva—Crohn's disease	0.0019	0.0136	CbGeAlD
Zonisamide—CA12—digestive system—Crohn's disease	0.00186	0.0133	CbGeAlD
Zonisamide—AOX1—mammalian vulva—Crohn's disease	0.00177	0.0126	CbGeAlD
Zonisamide—SCN5A—digestive system—Crohn's disease	0.00161	0.0116	CbGeAlD
Zonisamide—AOX1—digestive system—Crohn's disease	0.00155	0.0111	CbGeAlD
Zonisamide—CA3—lymph node—Crohn's disease	0.0015	0.0107	CbGeAlD
Zonisamide—CA1—lymphoid tissue—Crohn's disease	0.00149	0.0107	CbGeAlD
Zonisamide—CA1—digestive system—Crohn's disease	0.00147	0.0105	CbGeAlD
Zonisamide—MAOB—mammalian vulva—Crohn's disease	0.00136	0.00974	CbGeAlD
Zonisamide—SCN9A—lymph node—Crohn's disease	0.00133	0.00954	CbGeAlD
Zonisamide—CA2—epithelium—Crohn's disease	0.00125	0.00897	CbGeAlD
Zonisamide—CACNA1H—lymph node—Crohn's disease	0.00125	0.00894	CbGeAlD
Zonisamide—Malnutrition—Mercaptopurine—Crohn's disease	0.00123	0.00436	CcSEcCtD
Zonisamide—Peptic ulcer—Prednisone—Crohn's disease	0.00121	0.00429	CcSEcCtD
Zonisamide—CA2—smooth muscle tissue—Crohn's disease	0.00121	0.00864	CbGeAlD
Zonisamide—Libido decreased—Mesalazine—Crohn's disease	0.0012	0.00424	CcSEcCtD
Zonisamide—MAOB—digestive system—Crohn's disease	0.00119	0.00854	CbGeAlD
Zonisamide—CA2—skin of body—Crohn's disease	0.00119	0.00853	CbGeAlD
Zonisamide—Atrial fibrillation—Mesalazine—Crohn's disease	0.00117	0.00415	CcSEcCtD
Zonisamide—Thirst—Mesalazine—Crohn's disease	0.00116	0.00413	CcSEcCtD
Zonisamide—MAOA—mammalian vulva—Crohn's disease	0.00116	0.00831	CbGeAlD
Zonisamide—Dermatitis bullous—Mesalazine—Crohn's disease	0.00116	0.00411	CcSEcCtD
Zonisamide—Suicidal ideation—Prednisone—Crohn's disease	0.00115	0.00409	CcSEcCtD
Zonisamide—CA4—digestive system—Crohn's disease	0.00115	0.00823	CbGeAlD
Zonisamide—Arthritis—Mesalazine—Crohn's disease	0.00114	0.00404	CcSEcCtD
Zonisamide—Anaemia—Mercaptopurine—Crohn's disease	0.00114	0.00403	CcSEcCtD
Zonisamide—Osteoarthritis—Mesalazine—Crohn's disease	0.00111	0.00393	CcSEcCtD
Zonisamide—Leukopenia—Mercaptopurine—Crohn's disease	0.0011	0.0039	CcSEcCtD
Zonisamide—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.0011	0.0039	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.0011	0.00389	CcSEcCtD
Zonisamide—Affect lability—Mesalazine—Crohn's disease	0.00109	0.00387	CcSEcCtD
Zonisamide—CA2—mammalian vulva—Crohn's disease	0.00109	0.00778	CbGeAlD
Zonisamide—Neuritis—Prednisone—Crohn's disease	0.00108	0.00384	CcSEcCtD
Zonisamide—Glaucoma—Prednisone—Crohn's disease	0.00107	0.00381	CcSEcCtD
Zonisamide—Face oedema—Mesalazine—Crohn's disease	0.00107	0.0038	CcSEcCtD
Zonisamide—Mood swings—Mesalazine—Crohn's disease	0.00105	0.00372	CcSEcCtD
Zonisamide—Arthralgia—Mercaptopurine—Crohn's disease	0.00105	0.00371	CcSEcCtD
Zonisamide—CYP2C19—digestive system—Crohn's disease	0.00104	0.00745	CbGeAlD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00104	0.00369	CcSEcCtD
Zonisamide—Blood creatinine increased—Mesalazine—Crohn's disease	0.00104	0.00368	CcSEcCtD
Zonisamide—Pancreatitis—Azathioprine—Crohn's disease	0.00103	0.00366	CcSEcCtD
Zonisamide—Memory impairment—Prednisone—Crohn's disease	0.00103	0.00365	CcSEcCtD
Zonisamide—Liver function test abnormal—Mesalazine—Crohn's disease	0.00102	0.00363	CcSEcCtD
Zonisamide—MAOA—digestive system—Crohn's disease	0.00102	0.00729	CbGeAlD
Zonisamide—Dry skin—Mesalazine—Crohn's disease	0.00102	0.0036	CcSEcCtD
Zonisamide—Oedema—Mercaptopurine—Crohn's disease	0.001	0.00356	CcSEcCtD
Zonisamide—Pancytopenia—Azathioprine—Crohn's disease	0.000999	0.00354	CcSEcCtD
Zonisamide—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000998	0.00354	CcSEcCtD
Zonisamide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000983	0.00349	CcSEcCtD
Zonisamide—Petechiae—Prednisone—Crohn's disease	0.000982	0.00348	CcSEcCtD
Zonisamide—Gastritis—Mesalazine—Crohn's disease	0.000981	0.00348	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000978	0.00347	CcSEcCtD
Zonisamide—Skin disorder—Mercaptopurine—Crohn's disease	0.000975	0.00346	CcSEcCtD
Zonisamide—CA2—lymphoid tissue—Crohn's disease	0.000965	0.00691	CbGeAlD
Zonisamide—Influenza—Mesalazine—Crohn's disease	0.000958	0.0034	CcSEcCtD
Zonisamide—Dysphagia—Mesalazine—Crohn's disease	0.000958	0.0034	CcSEcCtD
Zonisamide—Anorexia—Mercaptopurine—Crohn's disease	0.000957	0.00339	CcSEcCtD
Zonisamide—CA2—digestive system—Crohn's disease	0.000953	0.00682	CbGeAlD
Zonisamide—CA5B—lymph node—Crohn's disease	0.000951	0.00681	CbGeAlD
Zonisamide—Eosinophilia—Mesalazine—Crohn's disease	0.000948	0.00336	CcSEcCtD
Zonisamide—Pneumonia—Azathioprine—Crohn's disease	0.000943	0.00335	CcSEcCtD
Zonisamide—Pancreatitis—Mesalazine—Crohn's disease	0.000939	0.00333	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00093	0.0033	CcSEcCtD
Zonisamide—SCN3A—lymph node—Crohn's disease	0.000924	0.00662	CbGeAlD
Zonisamide—Amenorrhoea—Prednisone—Crohn's disease	0.000919	0.00326	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000914	0.00324	CcSEcCtD
Zonisamide—Pancytopenia—Mesalazine—Crohn's disease	0.00091	0.00323	CcSEcCtD
Zonisamide—Dysuria—Mesalazine—Crohn's disease	0.000896	0.00318	CcSEcCtD
Zonisamide—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000887	0.00315	CcSEcCtD
Zonisamide—Pollakiuria—Mesalazine—Crohn's disease	0.000885	0.00314	CcSEcCtD
Zonisamide—AOX1—lymph node—Crohn's disease	0.000885	0.00633	CbGeAlD
Zonisamide—Agranulocytosis—Azathioprine—Crohn's disease	0.000875	0.0031	CcSEcCtD
Zonisamide—Decreased appetite—Mercaptopurine—Crohn's disease	0.000873	0.00309	CcSEcCtD
Zonisamide—Weight increased—Mesalazine—Crohn's disease	0.000872	0.00309	CcSEcCtD
Zonisamide—Weight decreased—Mesalazine—Crohn's disease	0.000867	0.00307	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000867	0.00307	CcSEcCtD
Zonisamide—Leukocytosis—Prednisone—Crohn's disease	0.00086	0.00305	CcSEcCtD
Zonisamide—Pneumonia—Mesalazine—Crohn's disease	0.000859	0.00305	CcSEcCtD
Zonisamide—Depression—Mesalazine—Crohn's disease	0.000852	0.00302	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000847	0.003	CcSEcCtD
Zonisamide—CA1—lymph node—Crohn's disease	0.00084	0.00601	CbGeAlD
Zonisamide—Renal failure—Mesalazine—Crohn's disease	0.00084	0.00298	CcSEcCtD
Zonisamide—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000837	0.00297	CcSEcCtD
Zonisamide—Stomatitis—Mesalazine—Crohn's disease	0.000833	0.00295	CcSEcCtD
Zonisamide—Conjunctivitis—Mesalazine—Crohn's disease	0.00083	0.00294	CcSEcCtD
Zonisamide—Urinary tract infection—Mesalazine—Crohn's disease	0.00083	0.00294	CcSEcCtD
Zonisamide—Sweating—Mesalazine—Crohn's disease	0.000819	0.0029	CcSEcCtD
Zonisamide—Haematuria—Mesalazine—Crohn's disease	0.000814	0.00289	CcSEcCtD
Zonisamide—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000808	0.00287	CcSEcCtD
Zonisamide—Agranulocytosis—Mesalazine—Crohn's disease	0.000797	0.00283	CcSEcCtD
Zonisamide—Erythema multiforme—Azathioprine—Crohn's disease	0.000796	0.00282	CcSEcCtD
Zonisamide—Body temperature increased—Mercaptopurine—Crohn's disease	0.000793	0.00281	CcSEcCtD
Zonisamide—Rhinitis—Mesalazine—Crohn's disease	0.000769	0.00273	CcSEcCtD
Zonisamide—Pharyngitis—Mesalazine—Crohn's disease	0.000761	0.0027	CcSEcCtD
Zonisamide—Immune system disorder—Azathioprine—Crohn's disease	0.00076	0.0027	CcSEcCtD
Zonisamide—Mediastinal disorder—Azathioprine—Crohn's disease	0.000759	0.00269	CcSEcCtD
Zonisamide—Neuropathy—Prednisone—Crohn's disease	0.000758	0.00269	CcSEcCtD
Zonisamide—Urinary tract disorder—Mesalazine—Crohn's disease	0.000757	0.00269	CcSEcCtD
Zonisamide—Oedema peripheral—Mesalazine—Crohn's disease	0.000755	0.00268	CcSEcCtD
Zonisamide—Connective tissue disorder—Mesalazine—Crohn's disease	0.000753	0.00267	CcSEcCtD
Zonisamide—Urethral disorder—Mesalazine—Crohn's disease	0.000752	0.00267	CcSEcCtD
Zonisamide—Alopecia—Azathioprine—Crohn's disease	0.000744	0.00264	CcSEcCtD
Zonisamide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000739	0.00262	CcSEcCtD
Zonisamide—Oesophagitis—Prednisone—Crohn's disease	0.000738	0.00262	CcSEcCtD
Zonisamide—Ecchymosis—Prednisone—Crohn's disease	0.00073	0.00259	CcSEcCtD
Zonisamide—Erythema multiforme—Mesalazine—Crohn's disease	0.000725	0.00257	CcSEcCtD
Zonisamide—Eye disorder—Mesalazine—Crohn's disease	0.000717	0.00254	CcSEcCtD
Zonisamide—Tinnitus—Mesalazine—Crohn's disease	0.000715	0.00254	CcSEcCtD
Zonisamide—Hyperkinesia—Prednisone—Crohn's disease	0.000705	0.0025	CcSEcCtD
Zonisamide—Euphoric mood—Prednisone—Crohn's disease	0.000694	0.00246	CcSEcCtD
Zonisamide—Immune system disorder—Mesalazine—Crohn's disease	0.000693	0.00246	CcSEcCtD
Zonisamide—Mediastinal disorder—Mesalazine—Crohn's disease	0.000691	0.00245	CcSEcCtD
Zonisamide—Diarrhoea—Mercaptopurine—Crohn's disease	0.000687	0.00244	CcSEcCtD
Zonisamide—MAOB—lymph node—Crohn's disease	0.000682	0.00488	CbGeAlD
Zonisamide—Ill-defined disorder—Azathioprine—Crohn's disease	0.00068	0.00241	CcSEcCtD
Zonisamide—Alopecia—Mesalazine—Crohn's disease	0.000678	0.0024	CcSEcCtD
Zonisamide—Thrombophlebitis—Prednisone—Crohn's disease	0.000677	0.0024	CcSEcCtD
Zonisamide—Anaemia—Azathioprine—Crohn's disease	0.000677	0.0024	CcSEcCtD
Zonisamide—Mental disorder—Mesalazine—Crohn's disease	0.000672	0.00238	CcSEcCtD
Zonisamide—Malaise—Azathioprine—Crohn's disease	0.000661	0.00234	CcSEcCtD
Zonisamide—Flatulence—Mesalazine—Crohn's disease	0.000658	0.00233	CcSEcCtD
Zonisamide—CA4—lymph node—Crohn's disease	0.000657	0.0047	CbGeAlD
Zonisamide—Leukopenia—Azathioprine—Crohn's disease	0.000656	0.00233	CcSEcCtD
Zonisamide—Tension—Mesalazine—Crohn's disease	0.000655	0.00232	CcSEcCtD
Zonisamide—Dysgeusia—Mesalazine—Crohn's disease	0.000654	0.00232	CcSEcCtD
Zonisamide—Nervousness—Mesalazine—Crohn's disease	0.000648	0.0023	CcSEcCtD
Zonisamide—Muscle spasms—Mesalazine—Crohn's disease	0.000642	0.00228	CcSEcCtD
Zonisamide—Vomiting—Mercaptopurine—Crohn's disease	0.000638	0.00226	CcSEcCtD
Zonisamide—Injury—Prednisone—Crohn's disease	0.000638	0.00226	CcSEcCtD
Zonisamide—Rash—Mercaptopurine—Crohn's disease	0.000633	0.00224	CcSEcCtD
Zonisamide—Dermatitis—Mercaptopurine—Crohn's disease	0.000632	0.00224	CcSEcCtD
Zonisamide—Tremor—Mesalazine—Crohn's disease	0.000625	0.00222	CcSEcCtD
Zonisamide—Amnesia—Prednisone—Crohn's disease	0.000624	0.00221	CcSEcCtD
Zonisamide—Arthralgia—Azathioprine—Crohn's disease	0.000624	0.00221	CcSEcCtD
Zonisamide—Myalgia—Azathioprine—Crohn's disease	0.000624	0.00221	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00062	0.0022	CcSEcCtD
Zonisamide—Ill-defined disorder—Mesalazine—Crohn's disease	0.000619	0.0022	CcSEcCtD
Zonisamide—Anaemia—Mesalazine—Crohn's disease	0.000617	0.00219	CcSEcCtD
Zonisamide—Discomfort—Azathioprine—Crohn's disease	0.000616	0.00219	CcSEcCtD
Zonisamide—CYP3A4—digestive system—Crohn's disease	0.000615	0.0044	CbGeAlD
Zonisamide—Malaise—Mesalazine—Crohn's disease	0.000602	0.00213	CcSEcCtD
Zonisamide—Cardiac failure—Prednisone—Crohn's disease	0.000601	0.00213	CcSEcCtD
Zonisamide—Vertigo—Mesalazine—Crohn's disease	0.0006	0.00213	CcSEcCtD
Zonisamide—Syncope—Mesalazine—Crohn's disease	0.000599	0.00212	CcSEcCtD
Zonisamide—Leukopenia—Mesalazine—Crohn's disease	0.000597	0.00212	CcSEcCtD
Zonisamide—Nausea—Mercaptopurine—Crohn's disease	0.000596	0.00211	CcSEcCtD
Zonisamide—Infection—Azathioprine—Crohn's disease	0.000594	0.00211	CcSEcCtD
Zonisamide—Palpitations—Mesalazine—Crohn's disease	0.00059	0.00209	CcSEcCtD
Zonisamide—Loss of consciousness—Mesalazine—Crohn's disease	0.000587	0.00208	CcSEcCtD
Zonisamide—Osteoarthritis—Prednisone—Crohn's disease	0.000586	0.00208	CcSEcCtD
Zonisamide—Thrombocytopenia—Azathioprine—Crohn's disease	0.000586	0.00208	CcSEcCtD
Zonisamide—Cough—Mesalazine—Crohn's disease	0.000582	0.00207	CcSEcCtD
Zonisamide—MAOA—lymph node—Crohn's disease	0.000582	0.00416	CbGeAlD
Zonisamide—Skin disorder—Azathioprine—Crohn's disease	0.000581	0.00206	CcSEcCtD
Zonisamide—Affect lability—Prednisone—Crohn's disease	0.000577	0.00205	CcSEcCtD
Zonisamide—Hypertension—Mesalazine—Crohn's disease	0.000576	0.00204	CcSEcCtD
Zonisamide—Psychotic disorder—Prednisone—Crohn's disease	0.000573	0.00203	CcSEcCtD
Zonisamide—Myalgia—Mesalazine—Crohn's disease	0.000568	0.00202	CcSEcCtD
Zonisamide—Chest pain—Mesalazine—Crohn's disease	0.000568	0.00202	CcSEcCtD
Zonisamide—Arthralgia—Mesalazine—Crohn's disease	0.000568	0.00202	CcSEcCtD
Zonisamide—Anxiety—Mesalazine—Crohn's disease	0.000566	0.00201	CcSEcCtD
Zonisamide—Face oedema—Prednisone—Crohn's disease	0.000566	0.00201	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000564	0.002	CcSEcCtD
Zonisamide—Discomfort—Mesalazine—Crohn's disease	0.000561	0.00199	CcSEcCtD
Zonisamide—Irritability—Prednisone—Crohn's disease	0.00056	0.00199	CcSEcCtD
Zonisamide—Hypotension—Azathioprine—Crohn's disease	0.000559	0.00198	CcSEcCtD
Zonisamide—Dry mouth—Mesalazine—Crohn's disease	0.000556	0.00197	CcSEcCtD
Zonisamide—Mood swings—Prednisone—Crohn's disease	0.000556	0.00197	CcSEcCtD
Zonisamide—Confusional state—Mesalazine—Crohn's disease	0.000549	0.00195	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000545	0.00193	CcSEcCtD
Zonisamide—Oedema—Mesalazine—Crohn's disease	0.000545	0.00193	CcSEcCtD
Zonisamide—CA2—lymph node—Crohn's disease	0.000544	0.0039	CbGeAlD
Zonisamide—Infection—Mesalazine—Crohn's disease	0.000541	0.00192	CcSEcCtD
Zonisamide—Dry skin—Prednisone—Crohn's disease	0.000538	0.00191	CcSEcCtD
Zonisamide—Shock—Mesalazine—Crohn's disease	0.000536	0.0019	CcSEcCtD
Zonisamide—Nervous system disorder—Mesalazine—Crohn's disease	0.000534	0.00189	CcSEcCtD
Zonisamide—Hypokalaemia—Prednisone—Crohn's disease	0.000534	0.00189	CcSEcCtD
Zonisamide—Thrombocytopenia—Mesalazine—Crohn's disease	0.000533	0.00189	CcSEcCtD
Zonisamide—Tachycardia—Mesalazine—Crohn's disease	0.000532	0.00189	CcSEcCtD
Zonisamide—Skin disorder—Mesalazine—Crohn's disease	0.000529	0.00188	CcSEcCtD
Zonisamide—Hyperhidrosis—Mesalazine—Crohn's disease	0.000527	0.00187	CcSEcCtD
Zonisamide—Anorexia—Mesalazine—Crohn's disease	0.000519	0.00184	CcSEcCtD
Zonisamide—Muscular weakness—Prednisone—Crohn's disease	0.000517	0.00183	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000517	0.00183	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000516	0.00183	CcSEcCtD
Zonisamide—Hypotension—Mesalazine—Crohn's disease	0.000509	0.00181	CcSEcCtD
Zonisamide—Pancreatitis—Prednisone—Crohn's disease	0.000497	0.00176	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000496	0.00176	CcSEcCtD
Zonisamide—Feeling abnormal—Azathioprine—Crohn's disease	0.000493	0.00175	CcSEcCtD
Zonisamide—Insomnia—Mesalazine—Crohn's disease	0.000493	0.00175	CcSEcCtD
Zonisamide—Paraesthesia—Mesalazine—Crohn's disease	0.000489	0.00173	CcSEcCtD
Zonisamide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000489	0.00173	CcSEcCtD
Zonisamide—Dyspnoea—Mesalazine—Crohn's disease	0.000486	0.00172	CcSEcCtD
Zonisamide—Somnolence—Mesalazine—Crohn's disease	0.000484	0.00172	CcSEcCtD
Zonisamide—Dyspepsia—Mesalazine—Crohn's disease	0.00048	0.0017	CcSEcCtD
Zonisamide—Decreased appetite—Mesalazine—Crohn's disease	0.000474	0.00168	CcSEcCtD
Zonisamide—Body temperature increased—Azathioprine—Crohn's disease	0.000473	0.00168	CcSEcCtD
Zonisamide—Abdominal pain—Azathioprine—Crohn's disease	0.000473	0.00168	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00047	0.00167	CcSEcCtD
Zonisamide—Fatigue—Mesalazine—Crohn's disease	0.00047	0.00167	CcSEcCtD
Zonisamide—Erectile dysfunction—Prednisone—Crohn's disease	0.000467	0.00166	CcSEcCtD
Zonisamide—Constipation—Mesalazine—Crohn's disease	0.000466	0.00165	CcSEcCtD
Zonisamide—Weight increased—Prednisone—Crohn's disease	0.000461	0.00164	CcSEcCtD
Zonisamide—Weight decreased—Prednisone—Crohn's disease	0.000459	0.00163	CcSEcCtD
Zonisamide—Depression—Prednisone—Crohn's disease	0.000451	0.0016	CcSEcCtD
Zonisamide—Feeling abnormal—Mesalazine—Crohn's disease	0.000449	0.00159	CcSEcCtD
Zonisamide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000445	0.00158	CcSEcCtD
Zonisamide—Neuropathy peripheral—Prednisone—Crohn's disease	0.000443	0.00157	CcSEcCtD
Zonisamide—Hypersensitivity—Azathioprine—Crohn's disease	0.000441	0.00156	CcSEcCtD
Zonisamide—Urticaria—Mesalazine—Crohn's disease	0.000433	0.00153	CcSEcCtD
Zonisamide—Abdominal pain—Mesalazine—Crohn's disease	0.000431	0.00153	CcSEcCtD
Zonisamide—Body temperature increased—Mesalazine—Crohn's disease	0.000431	0.00153	CcSEcCtD
Zonisamide—Bradycardia—Prednisone—Crohn's disease	0.000413	0.00146	CcSEcCtD
Zonisamide—Diarrhoea—Azathioprine—Crohn's disease	0.000409	0.00145	CcSEcCtD
Zonisamide—Hallucination—Prednisone—Crohn's disease	0.000404	0.00143	CcSEcCtD
Zonisamide—Hypersensitivity—Mesalazine—Crohn's disease	0.000401	0.00142	CcSEcCtD
Zonisamide—Connective tissue disorder—Prednisone—Crohn's disease	0.000399	0.00141	CcSEcCtD
Zonisamide—Dizziness—Azathioprine—Crohn's disease	0.000395	0.0014	CcSEcCtD
Zonisamide—Asthenia—Mesalazine—Crohn's disease	0.000391	0.00139	CcSEcCtD
Zonisamide—Pruritus—Mesalazine—Crohn's disease	0.000385	0.00137	CcSEcCtD
Zonisamide—Vomiting—Azathioprine—Crohn's disease	0.00038	0.00135	CcSEcCtD
Zonisamide—Eye disorder—Prednisone—Crohn's disease	0.000379	0.00134	CcSEcCtD
Zonisamide—Rash—Azathioprine—Crohn's disease	0.000377	0.00134	CcSEcCtD
Zonisamide—Dermatitis—Azathioprine—Crohn's disease	0.000377	0.00134	CcSEcCtD
Zonisamide—Headache—Azathioprine—Crohn's disease	0.000375	0.00133	CcSEcCtD
Zonisamide—Diarrhoea—Mesalazine—Crohn's disease	0.000373	0.00132	CcSEcCtD
Zonisamide—Immune system disorder—Prednisone—Crohn's disease	0.000366	0.0013	CcSEcCtD
Zonisamide—Dizziness—Mesalazine—Crohn's disease	0.00036	0.00128	CcSEcCtD
Zonisamide—Alopecia—Prednisone—Crohn's disease	0.000358	0.00127	CcSEcCtD
Zonisamide—Mental disorder—Prednisone—Crohn's disease	0.000355	0.00126	CcSEcCtD
Zonisamide—Nausea—Azathioprine—Crohn's disease	0.000355	0.00126	CcSEcCtD
Zonisamide—Malnutrition—Prednisone—Crohn's disease	0.000353	0.00125	CcSEcCtD
Zonisamide—Vomiting—Mesalazine—Crohn's disease	0.000346	0.00123	CcSEcCtD
Zonisamide—Rash—Mesalazine—Crohn's disease	0.000343	0.00122	CcSEcCtD
Zonisamide—Dermatitis—Mesalazine—Crohn's disease	0.000343	0.00122	CcSEcCtD
Zonisamide—Headache—Mesalazine—Crohn's disease	0.000341	0.00121	CcSEcCtD
Zonisamide—Ill-defined disorder—Prednisone—Crohn's disease	0.000328	0.00116	CcSEcCtD
Zonisamide—Anaemia—Prednisone—Crohn's disease	0.000326	0.00116	CcSEcCtD
Zonisamide—Agitation—Prednisone—Crohn's disease	0.000325	0.00115	CcSEcCtD
Zonisamide—Nausea—Mesalazine—Crohn's disease	0.000324	0.00115	CcSEcCtD
Zonisamide—Malaise—Prednisone—Crohn's disease	0.000318	0.00113	CcSEcCtD
Zonisamide—Vertigo—Prednisone—Crohn's disease	0.000317	0.00113	CcSEcCtD
Zonisamide—Syncope—Prednisone—Crohn's disease	0.000317	0.00112	CcSEcCtD
Zonisamide—Loss of consciousness—Prednisone—Crohn's disease	0.00031	0.0011	CcSEcCtD
Zonisamide—Convulsion—Prednisone—Crohn's disease	0.000306	0.00109	CcSEcCtD
Zonisamide—Hypertension—Prednisone—Crohn's disease	0.000305	0.00108	CcSEcCtD
Zonisamide—Arthralgia—Prednisone—Crohn's disease	0.000301	0.00107	CcSEcCtD
Zonisamide—Myalgia—Prednisone—Crohn's disease	0.000301	0.00107	CcSEcCtD
Zonisamide—Anxiety—Prednisone—Crohn's disease	0.0003	0.00106	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000299	0.00106	CcSEcCtD
Zonisamide—Discomfort—Prednisone—Crohn's disease	0.000297	0.00105	CcSEcCtD
Zonisamide—Oedema—Prednisone—Crohn's disease	0.000288	0.00102	CcSEcCtD
Zonisamide—Infection—Prednisone—Crohn's disease	0.000286	0.00102	CcSEcCtD
Zonisamide—Shock—Prednisone—Crohn's disease	0.000284	0.00101	CcSEcCtD
Zonisamide—Nervous system disorder—Prednisone—Crohn's disease	0.000283	0.001	CcSEcCtD
Zonisamide—Tachycardia—Prednisone—Crohn's disease	0.000281	0.000998	CcSEcCtD
Zonisamide—Skin disorder—Prednisone—Crohn's disease	0.00028	0.000993	CcSEcCtD
Zonisamide—Hyperhidrosis—Prednisone—Crohn's disease	0.000279	0.000988	CcSEcCtD
Zonisamide—Anorexia—Prednisone—Crohn's disease	0.000275	0.000974	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000263	0.000931	CcSEcCtD
Zonisamide—Insomnia—Prednisone—Crohn's disease	0.000261	0.000925	CcSEcCtD
Zonisamide—Paraesthesia—Prednisone—Crohn's disease	0.000259	0.000918	CcSEcCtD
Zonisamide—Dyspepsia—Prednisone—Crohn's disease	0.000254	0.0009	CcSEcCtD
Zonisamide—Decreased appetite—Prednisone—Crohn's disease	0.000251	0.000889	CcSEcCtD
Zonisamide—Fatigue—Prednisone—Crohn's disease	0.000248	0.000881	CcSEcCtD
Zonisamide—Constipation—Prednisone—Crohn's disease	0.000246	0.000874	CcSEcCtD
Zonisamide—Feeling abnormal—Prednisone—Crohn's disease	0.000238	0.000842	CcSEcCtD
Zonisamide—Gastrointestinal pain—Prednisone—Crohn's disease	0.000236	0.000836	CcSEcCtD
Zonisamide—Urticaria—Prednisone—Crohn's disease	0.000229	0.000812	CcSEcCtD
Zonisamide—Abdominal pain—Prednisone—Crohn's disease	0.000228	0.000808	CcSEcCtD
Zonisamide—Body temperature increased—Prednisone—Crohn's disease	0.000228	0.000808	CcSEcCtD
Zonisamide—Hypersensitivity—Prednisone—Crohn's disease	0.000212	0.000753	CcSEcCtD
Zonisamide—Asthenia—Prednisone—Crohn's disease	0.000207	0.000733	CcSEcCtD
Zonisamide—Pruritus—Prednisone—Crohn's disease	0.000204	0.000723	CcSEcCtD
Zonisamide—Diarrhoea—Prednisone—Crohn's disease	0.000197	0.000699	CcSEcCtD
Zonisamide—Dizziness—Prednisone—Crohn's disease	0.000191	0.000676	CcSEcCtD
Zonisamide—Vomiting—Prednisone—Crohn's disease	0.000183	0.00065	CcSEcCtD
Zonisamide—Rash—Prednisone—Crohn's disease	0.000182	0.000645	CcSEcCtD
Zonisamide—Dermatitis—Prednisone—Crohn's disease	0.000182	0.000644	CcSEcCtD
Zonisamide—Headache—Prednisone—Crohn's disease	0.000181	0.00064	CcSEcCtD
Zonisamide—Nausea—Prednisone—Crohn's disease	0.000171	0.000607	CcSEcCtD
Zonisamide—CA14—Metabolism—MTMR3—Crohn's disease	4.95e-05	0.00338	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—JAK2—Crohn's disease	4.94e-05	0.00337	CbGpPWpGaD
Zonisamide—CACNA1G—NCAM signaling for neurite out-growth—IL6—Crohn's disease	4.93e-05	0.00336	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PLA2G4F—Crohn's disease	4.91e-05	0.00335	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—IL10—Crohn's disease	4.89e-05	0.00333	CbGpPWpGaD
Zonisamide—CA6—Metabolism—MTMR3—Crohn's disease	4.82e-05	0.00329	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—MTMR3—Crohn's disease	4.82e-05	0.00329	CbGpPWpGaD
Zonisamide—CACNA1H—NCAM signaling for neurite out-growth—IL6—Crohn's disease	4.77e-05	0.00325	CbGpPWpGaD
Zonisamide—CA7—Metabolism—MTMR3—Crohn's disease	4.5e-05	0.00307	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—MTMR3—Crohn's disease	4.5e-05	0.00307	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—SMAD3—Crohn's disease	4.29e-05	0.00292	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—STAT3—Crohn's disease	4.26e-05	0.00291	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—STAT3—Crohn's disease	4.26e-05	0.00291	CbGpPWpGaD
Zonisamide—SCN1B—Axon guidance—IL6—Crohn's disease	4.17e-05	0.00285	CbGpPWpGaD
Zonisamide—SCN2B—Axon guidance—IL6—Crohn's disease	4.17e-05	0.00285	CbGpPWpGaD
Zonisamide—CA12—Metabolism—MTMR3—Crohn's disease	4.17e-05	0.00284	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—SMAD3—Crohn's disease	4.06e-05	0.00277	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—TYK2—Crohn's disease	3.92e-05	0.00267	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PLA2G4F—Crohn's disease	3.91e-05	0.00267	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—STAT3—Crohn's disease	3.9e-05	0.00266	CbGpPWpGaD
Zonisamide—CA14—Metabolism—FADS1—Crohn's disease	3.86e-05	0.00263	CbGpPWpGaD
Zonisamide—SCN4B—Axon guidance—IL6—Crohn's disease	3.82e-05	0.0026	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—FADS1—Crohn's disease	3.76e-05	0.00256	CbGpPWpGaD
Zonisamide—CA6—Metabolism—FADS1—Crohn's disease	3.76e-05	0.00256	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PLA2G4F—Crohn's disease	3.75e-05	0.00256	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—JAK2—Crohn's disease	3.74e-05	0.00255	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—TYK2—Crohn's disease	3.71e-05	0.00253	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—TNF—Crohn's disease	3.69e-05	0.00252	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—TNF—Crohn's disease	3.69e-05	0.00252	CbGpPWpGaD
Zonisamide—AOX1—Disease—RSPO3—Crohn's disease	3.68e-05	0.00251	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—STAT3—Crohn's disease	3.62e-05	0.00247	CbGpPWpGaD
Zonisamide—CA14—Metabolism—GPX4—Crohn's disease	3.61e-05	0.00246	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PLA2G4F—Crohn's disease	3.6e-05	0.00245	CbGpPWpGaD
Zonisamide—SCN3B—Axon guidance—IL6—Crohn's disease	3.55e-05	0.00242	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—JAK2—Crohn's disease	3.54e-05	0.00242	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PLA2G4F—Crohn's disease	3.53e-05	0.0024	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—GPX4—Crohn's disease	3.52e-05	0.0024	CbGpPWpGaD
Zonisamide—CA6—Metabolism—GPX4—Crohn's disease	3.52e-05	0.0024	CbGpPWpGaD
Zonisamide—CA7—Metabolism—FADS1—Crohn's disease	3.51e-05	0.00239	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—FADS1—Crohn's disease	3.51e-05	0.00239	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—IL10—Crohn's disease	3.5e-05	0.00239	CbGpPWpGaD
Zonisamide—AOX1—Disease—SEL1L—Crohn's disease	3.49e-05	0.00238	CbGpPWpGaD
Zonisamide—CA14—Metabolism—GCKR—Crohn's disease	3.49e-05	0.00238	CbGpPWpGaD
Zonisamide—CA6—Metabolism—GCKR—Crohn's disease	3.4e-05	0.00232	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—GCKR—Crohn's disease	3.4e-05	0.00232	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—TNF—Crohn's disease	3.37e-05	0.0023	CbGpPWpGaD
Zonisamide—CA4—Metabolism—MTMR3—Crohn's disease	3.33e-05	0.00227	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—GPX4—Crohn's disease	3.29e-05	0.00224	CbGpPWpGaD
Zonisamide—CA7—Metabolism—GPX4—Crohn's disease	3.29e-05	0.00224	CbGpPWpGaD
Zonisamide—CA13—Metabolism—ALB—Crohn's disease	3.28e-05	0.00224	CbGpPWpGaD
Zonisamide—CA12—Metabolism—FADS1—Crohn's disease	3.25e-05	0.00222	CbGpPWpGaD
Zonisamide—CA2—Metabolism—MTMR3—Crohn's disease	3.19e-05	0.00217	CbGpPWpGaD
Zonisamide—CA7—Metabolism—GCKR—Crohn's disease	3.17e-05	0.00216	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—GCKR—Crohn's disease	3.17e-05	0.00216	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	3.17e-05	0.00216	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PLA2G4F—Crohn's disease	3.16e-05	0.00216	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—SMAD3—Crohn's disease	3.16e-05	0.00215	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—TNF—Crohn's disease	3.14e-05	0.00214	CbGpPWpGaD
Zonisamide—AOX1—Disease—LTF—Crohn's disease	3.13e-05	0.00213	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—SMAD3—Crohn's disease	3.06e-05	0.00209	CbGpPWpGaD
Zonisamide—CA1—Metabolism—MTMR3—Crohn's disease	3.06e-05	0.00209	CbGpPWpGaD
Zonisamide—CA12—Metabolism—GPX4—Crohn's disease	3.04e-05	0.00208	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—SMAD3—Crohn's disease	3e-05	0.00205	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—MTMR3—Crohn's disease	3e-05	0.00204	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PLA2G4F—Crohn's disease	2.98e-05	0.00203	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—IL6—Crohn's disease	2.98e-05	0.00203	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—IL6—Crohn's disease	2.98e-05	0.00203	CbGpPWpGaD
Zonisamide—CA12—Metabolism—GCKR—Crohn's disease	2.94e-05	0.002	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—TYK2—Crohn's disease	2.89e-05	0.00197	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—SMAD3—Crohn's disease	2.87e-05	0.00196	CbGpPWpGaD
Zonisamide—CA13—Metabolism—PTGS2—Crohn's disease	2.87e-05	0.00196	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—TYK2—Crohn's disease	2.8e-05	0.00191	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—TYK2—Crohn's disease	2.8e-05	0.00191	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—SMAD3—Crohn's disease	2.76e-05	0.00188	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—SMAD3—Crohn's disease	2.76e-05	0.00188	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—JAK2—Crohn's disease	2.76e-05	0.00188	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—TYK2—Crohn's disease	2.75e-05	0.00187	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—IL6—Crohn's disease	2.72e-05	0.00186	CbGpPWpGaD
Zonisamide—CA9—Metabolism—MTMR3—Crohn's disease	2.69e-05	0.00183	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	2.67e-05	0.00182	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—JAK2—Crohn's disease	2.67e-05	0.00182	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—JAK2—Crohn's disease	2.67e-05	0.00182	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—SMAD3—Crohn's disease	2.66e-05	0.00182	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—TYK2—Crohn's disease	2.65e-05	0.00181	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—TYK2—Crohn's disease	2.63e-05	0.00179	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—JAK2—Crohn's disease	2.62e-05	0.00179	CbGpPWpGaD
Zonisamide—CA4—Metabolism—FADS1—Crohn's disease	2.59e-05	0.00177	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	2.56e-05	0.00175	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—MTMR3—Crohn's disease	2.53e-05	0.00173	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—IL6—Crohn's disease	2.53e-05	0.00173	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—JAK2—Crohn's disease	2.53e-05	0.00172	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—TYK2—Crohn's disease	2.52e-05	0.00172	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—TYK2—Crohn's disease	2.52e-05	0.00172	CbGpPWpGaD
Zonisamide—AOX1—Disease—GCKR—Crohn's disease	2.52e-05	0.00172	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—JAK2—Crohn's disease	2.51e-05	0.00171	CbGpPWpGaD
Zonisamide—CA2—Metabolism—FADS1—Crohn's disease	2.48e-05	0.00169	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—TYK2—Crohn's disease	2.43e-05	0.00166	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GPX4—Crohn's disease	2.43e-05	0.00165	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—JAK2—Crohn's disease	2.41e-05	0.00164	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—JAK2—Crohn's disease	2.41e-05	0.00164	CbGpPWpGaD
Zonisamide—CA1—Metabolism—FADS1—Crohn's disease	2.38e-05	0.00162	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GCKR—Crohn's disease	2.34e-05	0.0016	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—FADS1—Crohn's disease	2.34e-05	0.00159	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GPX4—Crohn's disease	2.33e-05	0.00159	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—JAK2—Crohn's disease	2.32e-05	0.00158	CbGpPWpGaD
Zonisamide—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.32e-05	0.00158	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GCKR—Crohn's disease	2.25e-05	0.00153	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GPX4—Crohn's disease	2.23e-05	0.00152	CbGpPWpGaD
Zonisamide—AOX1—Disease—SLC11A1—Crohn's disease	2.23e-05	0.00152	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GPX4—Crohn's disease	2.19e-05	0.00149	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GCKR—Crohn's disease	2.15e-05	0.00147	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—CXCL8—Crohn's disease	2.12e-05	0.00145	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GCKR—Crohn's disease	2.11e-05	0.00144	CbGpPWpGaD
Zonisamide—CA9—Metabolism—FADS1—Crohn's disease	2.09e-05	0.00143	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—TYK2—Crohn's disease	2.06e-05	0.00141	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—TYK2—Crohn's disease	2e-05	0.00136	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.99e-05	0.00136	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—FADS1—Crohn's disease	1.97e-05	0.00135	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—JAK2—Crohn's disease	1.97e-05	0.00134	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GPX4—Crohn's disease	1.96e-05	0.00134	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—TYK2—Crohn's disease	1.96e-05	0.00134	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—STAT3—Crohn's disease	1.96e-05	0.00133	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—IL6—Crohn's disease	1.92e-05	0.00131	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	1.91e-05	0.0013	CbGpPWpGaD
Zonisamide—AOX1—Disease—RBX1—Crohn's disease	1.91e-05	0.0013	CbGpPWpGaD
Zonisamide—AOX1—Disease—HSPA1B—Crohn's disease	1.91e-05	0.0013	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—JAK2—Crohn's disease	1.9e-05	0.0013	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	1.9e-05	0.0013	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GCKR—Crohn's disease	1.89e-05	0.00129	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TYK2—Crohn's disease	1.87e-05	0.00128	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—SMAD3—Crohn's disease	1.87e-05	0.00128	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—JAK2—Crohn's disease	1.87e-05	0.00128	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PLA2G4F—Crohn's disease	1.87e-05	0.00128	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—TNF—Crohn's disease	1.86e-05	0.00127	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—STAT3—Crohn's disease	1.86e-05	0.00127	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GPX4—Crohn's disease	1.85e-05	0.00126	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—IL1B—Crohn's disease	1.83e-05	0.00125	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—IL6—Crohn's disease	1.82e-05	0.00124	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TYK2—Crohn's disease	1.8e-05	0.00123	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TYK2—Crohn's disease	1.8e-05	0.00123	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—JAK2—Crohn's disease	1.79e-05	0.00122	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GCKR—Crohn's disease	1.79e-05	0.00122	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—TYK2—Crohn's disease	1.74e-05	0.00118	CbGpPWpGaD
Zonisamide—CA3—Metabolism—ALB—Crohn's disease	1.72e-05	0.00117	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—JAK2—Crohn's disease	1.72e-05	0.00117	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—JAK2—Crohn's disease	1.72e-05	0.00117	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—TYK2—Crohn's disease	1.71e-05	0.00117	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—STAT3—Crohn's disease	1.71e-05	0.00116	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—TNF—Crohn's disease	1.69e-05	0.00116	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.69e-05	0.00115	CbGpPWpGaD
Zonisamide—AOX1—Disease—UBE2D1—Crohn's disease	1.68e-05	0.00114	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—JAK2—Crohn's disease	1.66e-05	0.00113	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—JAK2—Crohn's disease	1.63e-05	0.00111	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—TNF—Crohn's disease	1.61e-05	0.0011	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—MTMR3—Crohn's disease	1.59e-05	0.00108	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PTGS2—Crohn's disease	1.51e-05	0.00103	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.5e-05	0.00102	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—STAT3—Crohn's disease	1.44e-05	0.000984	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—IL6—Crohn's disease	1.41e-05	0.000963	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—STAT3—Crohn's disease	1.4e-05	0.000953	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—STAT3—Crohn's disease	1.37e-05	0.000936	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—IL6—Crohn's disease	1.37e-05	0.000933	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—IL6—Crohn's disease	1.37e-05	0.000932	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—IL6—Crohn's disease	1.34e-05	0.000916	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—TNF—Crohn's disease	1.33e-05	0.000908	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.32e-05	0.000898	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—STAT3—Crohn's disease	1.31e-05	0.000895	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—IL6—Crohn's disease	1.3e-05	0.000884	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—IL6—Crohn's disease	1.29e-05	0.000876	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—STAT3—Crohn's disease	1.26e-05	0.00086	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—STAT3—Crohn's disease	1.26e-05	0.00086	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—TNF—Crohn's disease	1.25e-05	0.000852	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—FADS1—Crohn's disease	1.24e-05	0.000845	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—IL6—Crohn's disease	1.23e-05	0.000842	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—IL6—Crohn's disease	1.23e-05	0.000842	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.23e-05	0.000841	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TYK2—Crohn's disease	1.22e-05	0.000833	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—STAT3—Crohn's disease	1.22e-05	0.000829	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—TNF—Crohn's disease	1.21e-05	0.000825	CbGpPWpGaD
Zonisamide—AOX1—Disease—SMAD3—Crohn's disease	1.2e-05	0.000818	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—IL6—Crohn's disease	1.19e-05	0.000813	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—IL6—Crohn's disease	1.19e-05	0.000812	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—TNF—Crohn's disease	1.19e-05	0.00081	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—JAK2—Crohn's disease	1.16e-05	0.000794	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GPX4—Crohn's disease	1.16e-05	0.000791	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TNF—Crohn's disease	1.14e-05	0.000775	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GCKR—Crohn's disease	1.12e-05	0.000764	CbGpPWpGaD
Zonisamide—CA14—Metabolism—ALB—Crohn's disease	1.11e-05	0.000757	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TNF—Crohn's disease	1.09e-05	0.000744	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TNF—Crohn's disease	1.09e-05	0.000744	CbGpPWpGaD
Zonisamide—CA6—Metabolism—ALB—Crohn's disease	1.08e-05	0.000738	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—ALB—Crohn's disease	1.08e-05	0.000738	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.07e-05	0.000733	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—TNF—Crohn's disease	1.05e-05	0.000718	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—ALB—Crohn's disease	1.01e-05	0.000689	CbGpPWpGaD
Zonisamide—CA7—Metabolism—ALB—Crohn's disease	1.01e-05	0.000689	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—IL6—Crohn's disease	1.01e-05	0.000687	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—IL6—Crohn's disease	9.76e-06	0.000666	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTGS2—Crohn's disease	9.71e-06	0.000662	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—IL6—Crohn's disease	9.59e-06	0.000654	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTGS2—Crohn's disease	9.46e-06	0.000645	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTGS2—Crohn's disease	9.46e-06	0.000645	CbGpPWpGaD
Zonisamide—CA12—Metabolism—ALB—Crohn's disease	9.35e-06	0.000638	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—IL6—Crohn's disease	9.17e-06	0.000625	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	8.85e-06	0.000604	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTGS2—Crohn's disease	8.83e-06	0.000602	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTGS2—Crohn's disease	8.83e-06	0.000602	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—IL6—Crohn's disease	8.81e-06	0.000601	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—IL6—Crohn's disease	8.81e-06	0.000601	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—STAT3—Crohn's disease	8.55e-06	0.000583	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—IL6—Crohn's disease	8.5e-06	0.000579	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—IL6—Crohn's disease	8.37e-06	0.000571	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTGS2—Crohn's disease	8.18e-06	0.000558	CbGpPWpGaD
Zonisamide—AOX1—Disease—TYK2—Crohn's disease	7.82e-06	0.000534	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTMR3—Crohn's disease	7.53e-06	0.000513	CbGpPWpGaD
Zonisamide—AOX1—Disease—JAK2—Crohn's disease	7.46e-06	0.000509	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ALB—Crohn's disease	7.46e-06	0.000509	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TNF—Crohn's disease	7.4e-06	0.000505	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ALB—Crohn's disease	7.15e-06	0.000488	CbGpPWpGaD
Zonisamide—AOX1—Disease—CD4—Crohn's disease	7.08e-06	0.000483	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTGS2—Crohn's disease	7.02e-06	0.000479	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ALB—Crohn's disease	6.86e-06	0.000468	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ALB—Crohn's disease	6.72e-06	0.000459	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTGS2—Crohn's disease	6.53e-06	0.000445	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTGS2—Crohn's disease	6.26e-06	0.000427	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ALB—Crohn's disease	6.03e-06	0.000411	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—Crohn's disease	6e-06	0.000409	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—IL6—Crohn's disease	5.97e-06	0.000407	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—Crohn's disease	5.88e-06	0.000401	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—FADS1—Crohn's disease	5.86e-06	0.0004	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ALB—Crohn's disease	5.68e-06	0.000387	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GPX4—Crohn's disease	5.49e-06	0.000374	CbGpPWpGaD
Zonisamide—AOX1—Disease—STAT3—Crohn's disease	5.48e-06	0.000374	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	5.32e-06	0.000363	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GCKR—Crohn's disease	5.3e-06	0.000362	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—Crohn's disease	5.27e-06	0.00036	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—Crohn's disease	4.97e-06	0.000339	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTMR3—Crohn's disease	4.53e-06	0.000309	CbGpPWpGaD
Zonisamide—AOX1—Disease—IL6—Crohn's disease	3.83e-06	0.000261	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.79e-06	0.000258	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ALB—Crohn's disease	3.57e-06	0.000243	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—FADS1—Crohn's disease	3.53e-06	0.00024	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.32e-06	0.000226	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GPX4—Crohn's disease	3.3e-06	0.000225	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GCKR—Crohn's disease	3.19e-06	0.000217	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—Crohn's disease	3.12e-06	0.000213	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALB—Crohn's disease	1.69e-06	0.000115	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—Crohn's disease	1.48e-06	0.000101	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALB—Crohn's disease	1.01e-06	6.92e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—Crohn's disease	8.88e-07	6.05e-05	CbGpPWpGaD
